Kilgore and colleagues evaluated the efficacy of multiple HDAC inhibitors in the APPswe/PS1dE9 mouse model of AD and noted that vorinostat recovered memory functions and spatial awareness. Here, HDAC9 is linked to Alzheimer disease.